| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | beclometasone / formoterol / glycopyrronium (Trimbow®) |
| Formulation | 87 micrograms/5 micrograms/9 micrograms inhalation solution; 172 micrograms/5 micrograms/9 micrograms inhalation solution |
| Reference number | 3636 |
| Indication | Maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year |
| Company | Chiesi Farmaceutici S.p.A. |
| BNF chapter | Respiratory system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/05/2021 |